Loading company…
Based in Massachusetts, US, and founded in 1977 by Mark Abelson, MD, Ora, Inc. operates as a provider of ophthalmic clinical research services, focused on…
Based in Massachusetts, US, and founded in 1977 by Mark Abelson, MD, Ora, Inc. operates as a provider of ophthalmic clinical research services, focused on supporting pharmaceutical, biotech, and medical device companies in developing vision-related treatments. In July 2024, The Vistria Group acquired Ora, Inc., as part of recapitalisation. Ora, Inc. core service offerings include preclinical and clinical trial services, targeting various eye-related conditions such as retinal diseases, glaucoma, dry eye, and ocular surface disorders. The company's client base includes pharmaceutical and biotechnology firms looking to bring innovative therapies to market. The company operates on a B2B basis, executing contracts that include a range of clinical trial services and regulatory support. The capital will support Ora, Inc.'s expansion into new markets and enhance its global business operations. The company aims to broaden its services and market reach in the ophthalmic research sector, leveraging its established network and experience to serve an expanding client base.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in